Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Clinical trial NCT01217775 · UNKNOWN
Trial details
- NCT number
- NCT01217775
- Sponsor
- Pherin Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.